Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reevaluating therapies for bipolar depression.

Heinz Grunze1

  • 1Department of Psychiatry, Ludwig-Maximilians University, Munich, Germany. Heinz.Grunze@med.uni-muenchen.de

The Journal of Clinical Psychiatry
|July 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Clinical guidelines in bipolar disorder: applications and evaluation.

Frontiers in psychiatry·2025
Same author

The influence of depressive and manic symptoms on suicidal ideation in mixed mood states.

International journal of bipolar disorders·2025
Same author

Bipolar disorders and schizophrenia: discrete disorders?

Frontiers in psychiatry·2024
Same author

Treatment of Bipolar Disorders in Older Adults: A Review.

Focus (American Psychiatric Publishing)·2024
Same author

Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-Generation Antidepressants.

Focus (American Psychiatric Publishing)·2024
Same author

The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder.

Expert opinion on pharmacotherapy·2023

Antidepressants are effective for bipolar depression, even when combined with mood stabilizers, reducing mania risk. Further trials are needed to update guidelines for optimal patient care and reduce suicide risk.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Medicine

Background:

  • Bipolar depression treatment commonly uses antidepressants, lithium, and anticonvulsants.
  • Guidelines often caution against antidepressants due to potential mania induction.
  • Effective treatment is crucial to mitigate suicide risk and chronicity.

Purpose of the Study:

  • To evaluate the efficacy and safety of antidepressants in bipolar depression.
  • To assess the role of mood stabilizers in conjunction with antidepressants.
  • To inform revisions of current treatment guidelines.

Main Methods:

  • Review of existing pharmacotherapies and treatment guidelines.
  • Analysis of data on antidepressant efficacy and risk of mania.

Related Experiment Videos

  • Consideration of combination therapy with mood stabilizers.

    • Main Results:

    • Antidepressants demonstrate efficacy in treating bipolar depression.
    • Combination therapy with mood stabilizers, particularly SSRIs, can mitigate mania risk.
    • Mood stabilizer monotherapy is often recommended despite unproven antidepressant efficacy.

    Conclusions:

    • Current guidelines may need revision regarding antidepressant use in bipolar depression.
    • Adequately powered trials are necessary to confirm efficacy and safety of antidepressants.
    • Electroconvulsive therapy remains a viable option for refractory cases.